Results 271 to 280 of about 258,864 (309)
Some of the next articles are maybe not open access.
Clinical Journal of the American Society of Nephrology, 2021
Resistant hypertension is defined as BP that remains above goal despite the use of three antihypertensive medications at optimal doses of different classes, typically including a calcium channel blocker, a renin-angiotensin system (RAS) blocker, and a diuretic ([1][1]).
George, Thomas, Mahboob, Rahman
openaire +2 more sources
Resistant hypertension is defined as BP that remains above goal despite the use of three antihypertensive medications at optimal doses of different classes, typically including a calcium channel blocker, a renin-angiotensin system (RAS) blocker, and a diuretic ([1][1]).
George, Thomas, Mahboob, Rahman
openaire +2 more sources
American Journal of Kidney Diseases, 2018
Most women with dialysis-dependent chronic kidney disease (CKD) stage 5 (CKD stage 5D) are in the postmenopausal age group. Early menopause is reported for all CKD stages (stages 3-5D). The traditional definition of menopause is not applicable in CKD stage 5(D) because menses can resume with hormone replacement therapy or kidney transplantation ...
Kavitha, Vellanki, Susan, Hou
openaire +2 more sources
Most women with dialysis-dependent chronic kidney disease (CKD) stage 5 (CKD stage 5D) are in the postmenopausal age group. Early menopause is reported for all CKD stages (stages 3-5D). The traditional definition of menopause is not applicable in CKD stage 5(D) because menses can resume with hormone replacement therapy or kidney transplantation ...
Kavitha, Vellanki, Susan, Hou
openaire +2 more sources
Advances in Chronic Kidney Disease, 2011
Hypertension is found in more than 50% of pediatric patients with CKD. However, its prevalence varies according to the cause of CKD. It is relatively infrequent in children with structural disorders. Acquired renal disorders are associated with an increased prevalence of hypertension, similar to that of adults.
Rene G, VanDeVoorde, Mark M, Mitsnefes
openaire +2 more sources
Hypertension is found in more than 50% of pediatric patients with CKD. However, its prevalence varies according to the cause of CKD. It is relatively infrequent in children with structural disorders. Acquired renal disorders are associated with an increased prevalence of hypertension, similar to that of adults.
Rene G, VanDeVoorde, Mark M, Mitsnefes
openaire +2 more sources
EDTNA-ERCA Journal, 2006
The reality is that the majority of the CKD population have one or more co-morbid conditions with a known higher prevalence in ethnic minorities and lower socio-economic groups; combine this with the increase in childhood obesity and prevalence of diabetes and it is clear why we have an epidemic of CKD.
openaire +2 more sources
The reality is that the majority of the CKD population have one or more co-morbid conditions with a known higher prevalence in ethnic minorities and lower socio-economic groups; combine this with the increase in childhood obesity and prevalence of diabetes and it is clear why we have an epidemic of CKD.
openaire +2 more sources
American Journal of Kidney Diseases, 2013
Pulmonary arterial hypertension is a rare disease often associated with positive antinuclear antibody and high mortality. Pulmonary hypertension, which rarely is severe, occurs frequently in patients with chronic kidney disease (CKD). The prevalence of pulmonary hypertension ranges from 9%-39% in individuals with stage 5 CKD, 18.8%-68.8% in ...
Bolignano D +17 more
openaire +5 more sources
Pulmonary arterial hypertension is a rare disease often associated with positive antinuclear antibody and high mortality. Pulmonary hypertension, which rarely is severe, occurs frequently in patients with chronic kidney disease (CKD). The prevalence of pulmonary hypertension ranges from 9%-39% in individuals with stage 5 CKD, 18.8%-68.8% in ...
Bolignano D +17 more
openaire +5 more sources
Advances in Chronic Kidney Disease, 2011
The diagnosis of hereditary monogenic kidney diseases is frequently delayed, in part because of physicians' unfamiliarity with the relatively rare conditions or because of the late onset of symptoms in some patients. Molecular biology methods have clarified the underlying mutations in several types of CKD, and in the process have revealed previously ...
openaire +2 more sources
The diagnosis of hereditary monogenic kidney diseases is frequently delayed, in part because of physicians' unfamiliarity with the relatively rare conditions or because of the late onset of symptoms in some patients. Molecular biology methods have clarified the underlying mutations in several types of CKD, and in the process have revealed previously ...
openaire +2 more sources
BMJ, 2010
The concept of chronic kidney disease (CKD) is bad medicine only because we have made it so.1 The concepts of reduced renal excretory function and CKD have been conflated so people who do not have CKD—such as patients who have had a nephrectomy for reasons not related to the function of …
openaire +2 more sources
The concept of chronic kidney disease (CKD) is bad medicine only because we have made it so.1 The concepts of reduced renal excretory function and CKD have been conflated so people who do not have CKD—such as patients who have had a nephrectomy for reasons not related to the function of …
openaire +2 more sources
Ergocalciferol and Cholecalciferol in CKD
American Journal of Kidney Diseases, 2012The development of chronic kidney disease (CKD) is accompanied by a progressive decrease in the ability to produce 1,25-dihydroxyvitamin D. Pharmacological replacement with active vitamin D therefore has been a cornerstone of secondary hyperparathyroidism therapy in the end-stage renal disease population treated by long-term dialysis.
Sagar U, Nigwekar +2 more
openaire +2 more sources
Folia Pharmacologica Japonica, 2023
Diabetic kidney disease is a major cause of renal failure that urgently necessitates a breakthrough in disease management. Specific remedies are needed for preventing Type 2 diabetes which causes significant changes in an array of plasma metabolites. By untargeted metabolome analysis, phenyl sulfate (PS) increased with the progression of diabetes.
openaire +2 more sources
Diabetic kidney disease is a major cause of renal failure that urgently necessitates a breakthrough in disease management. Specific remedies are needed for preventing Type 2 diabetes which causes significant changes in an array of plasma metabolites. By untargeted metabolome analysis, phenyl sulfate (PS) increased with the progression of diabetes.
openaire +2 more sources
Erythrocytosis and CKD: A Review
American Journal of Kidney DiseasesErythrocytosis or polycythemia is defined as an increase in red blood cell concentration above the age- and sex-specific normal levels. Unlike anemia, which is very common in patients with chronic kidney disease (CKD), erythrocytosis is less frequent but requires specific understanding by health care professionals in order to provide the best care ...
Mabel, Aoun +2 more
openaire +2 more sources